Crescentic glomerulonephritis associated with levamisole-adulterated cocaine. A case report and a review of the literature
Abstract
Introduction: Levamisole is an anthelmintic drug, also known for its use as an immunomodulator which, because of its toxic effects, was withdrawn at the end of the 20th century. In 2005, because of an increase in the diagnosis of pauci-immune vasculitis among the population that uses psychoactive substances, the adulteration of cocaine for commercial purposes by combining it with levamisole was documented. Case Report: The case of a young adult with a history of Alport Syndrome and recent consumption of psychoactive substances is presented. A renal biopsy is performed, demonstrating the presence of pauci-immune crescentic glomerulonephritis. Therefore, this type of small vessel vasculitis with kidney involvement and immune complex deposition was associated with the use of cocaine adulterated with levamisole. Discussion: Levamisole, a drug approved by the FDA in 1991, acts as an immunomodulator, antiparasitic and adjuvant in chemotherapy. Levamisole produces a rheumatic syndrome characterized by the presence of glomerulonephritis, alveolar hemorrhage, retinal purpura, neutropenia, and agranulocytosis in association with the presence of anti-neutrophil cytoplasmic antibodies. Conclusion: levamisole is known for its anthelmintic and immunomodulatory properties, additionally it can produce ostensible toxic effects. Given the high consumption of cocaine among the indigent population, the presence of this adulterant constitutes a growing public health problem.
References
Amery WK, Bruynseels JP. Levamisole, the story and the lessons. Int J Immunopharmacol. 1992;14(3):481-6. doi: 10.1016/0192-0561(92)90179-o.
Larocque A, Hoffman RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol. 2012;50(4):231-41. doi: 10.3109/15563650.2012.665455.
Kudlacek O, Hofmaier T, Luf A, Mayer FP, Stockner T, Nagy C, et al. Cocaine adulteration. J Chem Neuroanat. 2017;83-84:75-81. doi: 10.1016/j.jchemneu.2017.06.001.
2020 World Drug Report. Drug use and health consequences. Vienna: report, 2020. 49 p.
Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010;88(3):408-11. doi: 10.1038/clpt.2010.156.
George TC, Freet DJ, Cross JM, Huzar TF. Levamisole-induced vasculitis. JAAPA. 2019;32(1):23-7. doi: 10.1097/01.JAA.0000547746.08181.f7.
Moinuddin I, Madhrira M, Bracamonte E, Thajudeen B, Sussman A. Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis. Pathol Res Pract. 2016;212(7):650-3. doi: 10.1016/j.prp.2016.03.008.
Karch SB, Mari F, Bartolini V, Bertol E. Aminorex poisoning in cocaine abusers. Int J Cardiol. 2012;158(3):344-6. doi: 10.1016/j.ijcard.2011.06.105.
Kumar D, Batal I, Jim B, Mendez B, Anis K. Unusual case of levamisole-induced dual-positive ANCA vasculitis and crescentic glomerulonephritis. BMJ Case Rep. 2018;2018:bcr2018225913. doi: 10.1136/bcr-2018-225913.
Collister D, Sathianathan C, Ryz K, Karpinski M, Bernstein K, Gibson IW. ANCA associated vasculitis secondary to levamisole-adultered cocaine with associated membranous nephropathy: a case series. Am J Nephrol. 2017;45(3):209-16. doi: 10.1159/000456553.
Dherange PA, Beatty N, Al-Khashman A. Levamisole-adulterated cocaine: a case of retiform purpura, cutaneous necrosis and neutropenia. BMJ Case Rep. 2015;2015:bcr2015211768. doi: 10.1136/bcr-2015-211768.
Miner J, Gruber P, Perry TL. Early excision and grafting, an alternative approach to the surgical management of large body surface area levamisole-adulterated cocaine induced skin necrosis. Burns. 2015;41(3):e34-40. doi: 10.1016/j.burns.2014.10.032.
Kopp SA, High WA, Green JJ. Levamisole-induced Wegener's granulomatosis following contaminated cocaine abuse. Skinmed. 2012;10(4):254-6.
Gulati S, Donato AA. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis. 2012;34(1):7-10. doi: 10.1007/s11239-012-0711-0.
Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol. 2011;17(4):193-6. doi: 10.1097/RHU.0b013e31820e6822.
Walsh NM, Green PJ, Burlingame RW, Pasternak S, Hanly JG. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol. 2010;37(12):1212-9. doi: 10.1111/j.1600-0560.2010.01613.x.
Khan TA, Cuchacovich R, Espinoza LR, Lata S, Patel NJ, Garcia-Valladares I, et al. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Semin Arthritis Rheum. 2011;41(3):445-54. doi: 10.1016/j.semarthrit.2011.04.010.
Graf J, Lynch K, Yeh CL, Tarter L, Richman N, Nguyen T, et al. Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum. 2011;63(12):3998-4001. doi: 10.1002/art.30590.
Poon SH, Baliog CR Jr, Sams RN, Robinson-Bostom L, Telang GH, Reginato AM. Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia. Semin Arthritis Rheum. 2011;41(3):434-44. doi: 10.1016/j.semarthrit.2011.05.009.
Veronese FV, Dode RS, Friderichs M, Thomé GG, da Silva DR, Schaefer PG, et al. Cocaine/levamisole-induced systemic vasculitis with retiform purpura and pauci-immune glomerulonephritis. Braz J Med Biol Res. 2016;49(5):e5244. doi: 10.1590/1414-431X20165244.
Friedman DR, Wolfsthal SD. Cocaine-induced pseudovasculitis. Mayo Clin Proc. 2005;80(5):671-3. doi: 10.4065/80.5.671.
Nolan AL, Jen KY. Pathologic manifestations of levamisole-adulterated cocaine exposure. Diagn Pathol. 2015;10:48. doi: 10.1186/s13000-015-0279-z.
Czuchlewski DR, Brackney M, Ewers C, Manna J, Fekrazad MH, Martinez A, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010;133(3):466-72. doi: 10.1309/AJCPOPQNBP5THKP1.
McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011;6(12):2799-805. doi: 10.2215/CJN.03440411.
Carrara C, Emili S, Lin M, Alpers CE. Necrotizing and crescentic glomerulonephritis with membranous nephropathy in a patient exposed to levamisole-adulterated cocaine. Clin Kidney J. 2016;9(2):234-8. doi: 10.1093/ckj/sfv141.
Roca-Argente L, Moll-Guillen JL, Espí-Reig J, Blanes-Julia M, García-Martínez AM, Pujol-Marco C, et al. Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report. Ann Transl Med. 2015;3(18):271. doi: 10.3978/j.issn.2305-5839.2015.10.29.
Carlson AQ, Tuot DS, Jen KY, Butcher B, Graf J, Sam R, et al. Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases. Medicine (Baltimore). 2014;93(17):290-7. doi: 10.1097/MD.0000000000000090.
Munoz CH, Vanegas AL, Arbelaez A, Restrepo M, Vasquez GM, Correa LA, et al. FRI0366 cocaine-levamisole induced vasculitis: a series of 11 cases. Ann Rheum Dis. 2016;75(Suppl. 2):567. doi: 10.1136/annrheumdis-2016-eular.2477.
Geetha D, Jefferson JA. ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis. 2020;75(1):124-37. doi: 10.1053/j.ajkd.2019.04.031.
Copyright (c) 2021 Revista de Nefrología, Diálisis y Trasplante
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
